International Stem Cell CORP·4

Dec 6, 8:02 AM ET

Kern Russell 4

4 · International Stem Cell CORP · Filed Dec 6, 2018

Insider Transaction Report

Form 4
Period: 2018-12-03
Semechkin Rouslan
Director10% Owner
Transactions
  • Sale

    Common Stock

    2018-12-03$1.67/sh1,800$3,006178,398 total
  • Exercise/Conversion

    Common Stock

    2018-12-03$1.09/sh+1,800$1,962180,198 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-12-031,80088,200 total
    Exercise: $1.09Exp: 2027-02-10Common Stock (90,000 underlying)
Footnotes (2)
  • [F1]The reported shares were sold in open market transactions through a broker-dealer at $1.67 per share.
  • [F2]The option, representing a total of 90,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months.

Documents

1 file
  • 4
    ownership.xmlPrimary